Streetbeat News

Stock Prices

BNED

IMMR

IWC

PRFZ

Barnes & Noble Education, Inc. (BNED) shares plummeted after announcing a short-term shareholder rights plan and a new equity investment deal with Immersion Corporation (IMMR) and other partners. The deal, closing in June 2024, will provide BNED with $95 million in new capital, aiming to strengthen its long-term financial position. This includes a $50 million equity investment and a $45 million equity rights offering led by Immersion, netting approximately $75 million after costs and reducing about $34 million of debt. Additionally, BNED plans to refinance its existing asset-backed loan facility, securing a $325 million facility maturing in 2028, and has adopted a short-term stockholder rights plan.

Portfolio Pulse from Lekha Gupta

April 16, 2024 | 4:30 pm

MAMO

Massimo Group's shares surged following a report of improved Q4 financial results year-over-year.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:18 pm

MARA

Financial analysis reveals a bullish trend in options trading for Marathon Digital Holdings (NASDAQ:MARA), with 58% of trades being bullish. The options activity suggests a target price range of $5.0 to $50.0. The company, focusing on digital asset mining, has seen its stock price decrease by -5.61% to $14.3, with an RSI indicating it may be oversold. Analysts have set an average target price of $25.75, with varying ratings from HC Wainwright & Co. and JP Morgan.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 4:16 pm

AI

Significant investors have shown a bullish stance on C3.ai (NYSE:AI) through options trading, as reported by Benzinga. The analysis of options activity reveals a predominant bullish sentiment with a focus on strike prices ranging from $21.0 to $34.0. Despite a mixed sentiment, 90% of the transactions are bullish. The volume and open interest in C3.ai's options have been closely monitored, indicating a strategic interest in the stock's future price movement. C3.ai, an enterprise AI company, has seen its stock price decrease by -0.91%, with a current price of $20.65. The next earnings report is expected in 43 days.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 4:16 pm

ITCI

Intra-Cellular Therapies Inc (NASDAQ:ITCI) announced positive topline results from Study 501 for lumateperone 42 mg as an adjunctive therapy for major depressive disorder (MDD), showing significant symptom relief. The results demonstrated a statistically significant reduction in the MADRS total score compared to placebo at Week 6. The company's shares surged 27.60% to $82.64 following the announcement. Further results from Study 502 are expected in the second quarter.

Portfolio Pulse from Vandana Singh

April 16, 2024 | 4:13 pm

BNED

CLDI

JAGX

MS

PACB

PALI

WISA

Morgan Stanley reported better-than-expected Q1 earnings with revenues of $15.1 billion and EPS of $2.02, surpassing consensus estimates. U.S. stocks showed mixed performance, with the Nasdaq Composite down 0.2%. Health care shares rose by 0.2%, while real estate shares fell by 1.8%. Jaguar Health, WiSA Technologies, and Palisade Bio saw significant stock increases due to new agreements and analyses. Conversely, Barnes & Noble Education, Calidi Biotherapeutics, and Pacific Biosciences faced sharp declines due to a shareholder rights plan, public offering pricing, and weak guidance, respectively.

Portfolio Pulse from Avi Kapoor

April 16, 2024 | 4:11 pm

GS

Goldman Sachs Group Inc (NYSE:GS) received varied analyst ratings after reporting strong Q1 results, highlighting its core strengths in investment banking and market share gains in Equities. Analysts from Argus Research, JPMorgan, BMO Capital Markets, Keefe, Bruyette & Woods, and Oppenheimer provided updates on their ratings and price targets, citing factors such as investment banking upturn, higher revenues, and strategic exits from consumer businesses as key drivers. Despite a slight decline in share price, the consensus points towards a positive outlook for Goldman Sachs.

Portfolio Pulse from Priya Nigam

April 16, 2024 | 4:09 pm

SNPO

JP Morgan analyst Cory Carpenter downgrades Snap One Holdings (NASDAQ:SNPO) from Overweight to Neutral and lowers the price target from $11 to $10.75.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:06 pm

RGTI

Rigetti Computing's stock is trading higher following the announcement of completing a three-year project to build and operate one of the first quantum computers in the UK.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:05 pm

AVTX

Avalo Therapeutics' stock price increased following an upgrade by Oppenheimer from Perform to Outperform, with a new price target set at $35.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:02 pm